Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 17501-17550 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT03210103
Primary Radiotherapy Versus Primary Surgery for HPV-Associated Oropharyngeal Cancer
NAActive, not recruiting
61 participants
Started: Jan 26, 2018 · Completed: Aug 15, 2028
1 condition1 sponsor9 locations
NCT03392987
A Safety and Efficacy Study of Cryopreserved OTL-200 for Treatment of Metachromatic Leukodystrophy (MLD)
PHASE2Active, not recruiting
10 participants
Started: Jan 25, 2018 · Completed: Jan 31, 2026
2 conditions2 sponsors1 location
NCT03575832
Watchful Living in Improving Quality of Life in Participants With Localized Prostate Cancer on Active Surveillance and Their Partners
NAActive, not recruiting
64 participants
Started: Jan 25, 2018 · Completed: Dec 31, 2025
9 conditions2 sponsors2 locations
NCT03774732
PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer
PHASE3Active, not recruiting
327 participants
Started: Jan 24, 2018 · Completed: Jul 22, 2027
3 conditions2 sponsors58 locations
NCT02876302
Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer
PHASE2Active, not recruiting
23 participants
Started: Jan 24, 2018 · Completed: Dec 31, 2025
1 condition2 sponsors4 locations
NCT03361020
Obstructive Sleep Apnea in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation
N/AActive, not recruiting
434 participants
Started: Jan 23, 2018 · Completed: Jul 10, 2028
2 conditions3 sponsors1 location
NCT03414229
A Study of Epacadostat, an IDO1 Inhibitor, in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma
PHASE2Active, not recruiting
30 participants
Started: Jan 23, 2018 · Completed: Jan 31, 2026
1 condition4 sponsors1 location
NCT03269669
Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
PHASE2Active, not recruiting
95 participants
Started: Jan 23, 2018 · Completed: Dec 31, 2025
5 conditions1 sponsor431 locations
NCT03283137
Combination of Pembrolizumab With TGR-1202 in Patients With Relapsed/Refractory CLL and B-cell NHL
PHASE1Active, not recruiting
20 participants
Started: Jan 23, 2018 · Completed: Dec 31, 2027
2 conditions1 sponsor3 locations
NCT03507010
Ledderhose Disease: Radiotherapy or Not?
PHASE3Active, not recruiting
84 participants
Started: Jan 23, 2018 · Completed: Mar 15, 2029
1 condition4 sponsors1 location
NCT03180502
Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma
PHASE2Active, not recruiting
120 participants
Started: Jan 23, 2018 · Completed: Jun 1, 2027
8 conditions2 sponsors34 locations
NCT03326076
Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry
N/AActive, not recruiting
4,000 participants
Started: Jan 23, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor72 locations
NCT03012529
Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics
PHASE4Active, not recruiting
843 participants
Started: Jan 22, 2018 · Completed: Dec 31, 2025
3 conditions1 sponsor30 locations
NCT03455452
Non-Interventional Study (NIS) of Nivolumab With or Without Ipilimumab in Participants With Advanced Kidney Cancer
N/AActive, not recruiting
600 participants
Started: Jan 21, 2018 · Completed: Nov 30, 2025
6 conditions1 sponsor1 location
NCT03405480
Pulmonary Rehabilitation to Improve Physical Capacity After Pulmonary Embolism
NAActive, not recruiting
209 participants
Started: Jan 20, 2018 · Completed: Mar 30, 2024
1 condition3 sponsors1 location
NCT03416894
Deep Brain Stimulation for Treatment Refractory PTSD
NAActive, not recruiting
5 participants
Started: Jan 19, 2018 · Completed: Nov 10, 2024
1 condition1 sponsor1 location
NCT02997228
Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study
PHASE3Active, not recruiting
120 participants
Started: Jan 19, 2018 · Completed: Jun 1, 2027
2 conditions2 sponsors446 locations
NCT03306680
SUNSET: SBRT for Ultra-central NSCLC- a Safety and Efficacy Trial
PHASE1Active, not recruiting
30 participants
Started: Jan 19, 2018 · Completed: Sep 30, 2026
1 condition1 sponsor7 locations
NCT03113461
MCI: CPAP Treatment of OSA (Memories2)
NAActive, not recruiting
327 participants
Started: Jan 19, 2018 · Completed: Jul 1, 2025
2 conditions2 sponsors4 locations
NCT04017520
Breast Milk: Influence of the Micro-transcriptome Profile on Atopy in Children Over Time
N/AActive, not recruiting
221 participants
Started: Jan 18, 2018 · Completed: Dec 30, 2027
4 conditions2 sponsors1 location
NCT03331250
Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE)
PHASE2Active, not recruiting
13 participants
Started: Jan 18, 2018 · Completed: Sep 1, 2025
2 conditions2 sponsors2 locations
NCT03404193
Venetoclax and Decitabine in Treating Participants With Relapsed/Refractory Acute Myeloid Leukemia or Relapsed High-Risk Myelodysplastic Syndrome
PHASE2Active, not recruiting
235 participants
Started: Jan 18, 2018 · Completed: Dec 31, 2025
15 conditions2 sponsors1 location
NCT03192462
TAA Specific Cytotoxic T Lymphocytes in Patients With Pancreatic Cancer
PHASE1/PHASE2Active, not recruiting
37 participants
Started: Jan 18, 2018 · Completed: May 1, 2027
1 condition6 sponsors3 locations
NCT03121209
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics (CREST-H)
PHASE3Active, not recruiting
385 participants
Started: Jan 18, 2018 · Completed: Jul 31, 2027
2 conditions6 sponsors58 locations
NCT03914196
Fontan Associated Liver Disease
N/AActive, not recruiting
50 participants
Started: Jan 18, 2018 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT03519048
Multicentric Comparative Study Between a Conventional and an Intensive Follow up Strategy After Treatment of a Head and Neck Squamous Cell Carcinoma
PHASE3Active, not recruiting
197 participants
Started: Jan 17, 2018 · Completed: Jan 31, 2031
1 condition2 sponsors1 location
NCT03403998
Neck Exercises in Patients With Temporomandibular Disorders
NAActive, not recruiting
113 participants
Started: Jan 17, 2018 · Completed: Jul 1, 2025
2 conditions1 sponsor1 location
NCT03410043
Osimertinib, Surgery, and Radiation Therapy in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer With EGFR Mutations, NORTHSTAR Study
PHASE2Active, not recruiting
173 participants
Started: Jan 17, 2018 · Completed: Apr 1, 2026
6 conditions3 sponsors4 locations
NCT02922036
Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients
NAActive, not recruiting
300 participants
Started: Jan 17, 2018 · Completed: Jun 30, 2026
1 condition1 sponsor68 locations
NCT03224000
Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer
PHASE2Active, not recruiting
90 participants
Started: Jan 17, 2018 · Completed: Dec 30, 2025
2 conditions2 sponsors1 location
NCT02911103
Deep Brain Stimulation Surgery for Focal Hand Dystonia
PHASE1/PHASE2Active, not recruiting
5 participants
Started: Jan 17, 2018 · Completed: Feb 2, 2029
3 conditions1 sponsor1 location
NCT03405155
Nivolumab in Treating Patients With Stage IIB-IIC Melanoma That Can Be Removed by Surgery
PHASE2Active, not recruiting
26 participants
Started: Jan 17, 2018 · Completed: Dec 31, 2025
1 condition2 sponsors4 locations
NCT03388619
Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy
PHASE1Active, not recruiting
30 participants
Started: Jan 17, 2018 · Completed: Dec 8, 2025
5 conditions1 sponsor1 location
NCT03366779
A Post Marketing Surveillance Study
PHASE4Active, not recruiting
20 participants
Started: Jan 16, 2018 · Completed: Dec 31, 2024
3 conditions1 sponsor2 locations
NCT03385993
Digital Rehabilitation Environment Augmenting Medical System
NAActive, not recruiting
100 participants
Started: Jan 16, 2018 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT03256916
Radiosensitizing Effect of Nelfinavir in Locally Advanced Carcinoma of Cervix
PHASE3Active, not recruiting
348 participants
Started: Jan 16, 2018 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT02965703
Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma
PHASE2Active, not recruiting
81 participants
Started: Jan 16, 2018 · Completed: Dec 13, 2025
2 conditions1 sponsor1 location
NCT03292497
Prospective Treatment Algorithm Guiding Repair of Severe Ischemic Mitral Regurgitation
NAActive, not recruiting
110 participants
Started: Jan 16, 2018 · Completed: Nov 30, 2028
1 condition1 sponsor1 location
NCT03247712
Neoadjuvant Immunoradiotherapy in Head & Neck Cancer
PHASE1/PHASE2Active, not recruiting
22 participants
Started: Jan 15, 2018 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT03197506
Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma
PHASE2Active, not recruiting
52 participants
Started: Jan 15, 2018 · Completed: Jun 6, 2028
3 conditions1 sponsor3 locations
NCT03406351
Air Pollution, Asthma and Circadian Clocks
N/AActive, not recruiting
20 participants
Started: Jan 15, 2018 · Completed: Jan 31, 2028
2 conditions1 sponsor1 location
NCT03350828
CHaractErizing CFTR Modulated Changes in Sweat Chloride and Their Association With Clinical Outcomes
N/AActive, not recruiting
5,000 participants
Started: Jan 15, 2018 · Completed: Dec 31, 2026
1 condition2 sponsors52 locations
NCT03275168
Developing a Dyadic Intervention for Sexually Transmitted Infection (STI)/HIV Prevention in Youth
NAActive, not recruiting
68 participants
Started: Jan 15, 2018 · Completed: Nov 1, 2025
1 condition2 sponsors1 location
NCT05076565
Wearable Airbag Technology to Mitigate Falls in Individuals With High Fall Risk
NAActive, not recruiting
200 participants
Started: Jan 14, 2018 · Completed: Dec 14, 2025
6 conditions1 sponsor1 location
NCT03379857
Prevalence of Strokes Secondary to a Reversible Cerebral Vasoconstriction Attributable to Cannabis Consumption in Young Subjects (≤ 45 Years) Hospitalized for an Ischaemic Stroke
NAActive, not recruiting
300 participants
Started: Jan 11, 2018 · Completed: Jan 11, 2025
2 conditions1 sponsor6 locations
NCT03374202
Safety and Tolerability of AAV8 Delivery of a Broadly Neutralizing Antibody in Adults Living With HIV: a Phase 1, Dose-escalation Trial
PHASE1Active, not recruiting
10 participants
Started: Jan 11, 2018 · Completed: Aug 8, 2026
1 condition1 sponsor1 location
NCT03168815
Low-Flow vs. High-Flow Nasal Cannula for Hypoxemic Immunocompromised Patients During Diagnostic Bronchoscopy
NAActive, not recruiting
98 participants
Started: Jan 10, 2018 · Completed: Dec 31, 2025
5 conditions2 sponsors1 location
NCT03420508
Treating Patients With Melanoma and ALK Alterations With Ensartinib
PHASE2Active, not recruiting
18 participants
Started: Jan 10, 2018 · Completed: Jan 31, 2026
1 condition2 sponsors4 locations
NCT03307356
The University of Pennsylvania Uterus Transplant for Uterine Factor Infertility Trial
NAActive, not recruiting
10 participants
Started: Jan 10, 2018 · Completed: Jul 1, 2029
4 conditions1 sponsor1 location
NCT03620617
Effect of Raspberry on Gut Microbiota and Metabolic Syndrome
NAActive, not recruiting
59 participants
Started: Jan 8, 2018 · Completed: Sep 30, 2025
2 conditions1 sponsor1 location